StockWatch
·
HomeLiveReports

Glenmark Life Sciences Ltd

BSE: 543322

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
6.25263.56520.87778.19Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
16.6722.8529.0235.20Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue640.41-7.1%689.12+2.4%672.89+14.4%587.98-2.3%601.85-7.3%649.54+1.2%641.84+26.6%506.88
Other Income22.40-1.7%22.78+63.5%13.93-5.4%14.72+63.8%8.98-10.9%10.09-3.5%10.46+22.6%8.53
Total Income662.82-6.9%711.89+3.7%686.82+14.0%602.70-1.3%610.83-7.4%659.63+1.1%652.30+26.6%515.41
EXPENSES
Expenditure450.59-9.2%496.10+7.2%462.77+8.0%428.56-4.3%447.85-4.4%468.34+0.3%467.15+20.4%387.96
Tax52.15-1.9%53.14+10.4%48.13+9.1%44.11+6.4%41.45-16.1%49.42+2.6%48.19+49.9%32.14
PROFIT
PBT212.22-1.7%215.80+8.8%198.39+13.9%174.14+6.8%162.98-14.8%191.29+3.3%185.15+45.3%127.46
Net Profit160.08-1.6%162.66+8.3%150.26+15.6%130.03+7.0%121.53-14.3%141.87+3.6%136.96+43.7%95.32
KEY METRICS
OPM %33.06%+1.93pp31.13%+0.57pp30.56%+0.09pp30.47%+1.84pp28.63%-1.92pp30.55%+5.77pp24.78%-0.37pp25.15%
NPM %24.15%+1.30pp22.85%+0.97pp21.88%+0.31pp21.57%+1.67pp19.90%-1.61pp21.51%+0.51pp21.00%+2.19pp18.81%
EPS13.04-1.4%13.23+8.0%12.25+15.6%10.60+7.0%9.91-14.3%11.57+3.5%11.18+1333.3%0.78

Corporate Events

Board MeetingALIVUS
2026
8Sep

Board Meeting

The Fifteenth (15th) Annual General Meeting (‘AGM’) of the C…

BSE Filing ↗
DividendALIVUS
2026
1Sep

₹5 / share

BSE Filing ↗
Board MeetingALIVUS
2026
18Aug

Board Meeting

The Board of Directors approved the share purchase agreement…

BSE Filing ↗
Board MeetingALIVUS
2026
30Jul

Board Meeting

The Board of Directors will consider and approve the Unaudit…

BSE Filing ↗
DividendALIVUS
2025
1Sep

₹5 / share

BSE Filing ↗
DividendALIVUS
2025
15May

₹5 / share

BSE Filing ↗
Board MeetingALIVUS
2024
24Oct

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing ↗
Board MeetingALIVUS
2024
25Apr

Board Meeting

Consider and approve Audited Financial Results

BSE Filing ↗
Board MeetingALIVUS
2024
23Jan

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing ↗
Board MeetingALIVUS
2023
20Oct

Board Meeting

Consider and approve Unaudited Financial Results for the sec…

BSE Filing ↗
DividendALIVUS
2023
17Oct

₹22.5 / share

BSE Filing ↗
Board MeetingALIVUS
2023
9Oct

Board Meeting

Consideration and approval of interim dividend for the finan…

BSE Filing ↗
DividendALIVUS
2023
6Oct

₹22.5 / share

BSE Filing ↗